The occurrence of cancer is typically associated with abnormal mutations in tumor suppressor genes and oncogenes, such as the aberrant expression of the anti-apoptotic protein B-cell lymphoma 2 (BCL-2) [1]. This evidence concerns the gene BCL2 and cancer.